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Controlling the colonisation of materials by microorganisms is important in a wide range of industries
and clinical settings. To date, the underlying mechanisms that govern the interactions of bacteria with
material surfaces remain poorly understood, limiting the ab initio design and engineering of biomaterials
to control bacterial attachment. Combinatorial approaches involving high-throughput screening have
emerged as key tools for identifying materials to control bacterial attachment. The hundreds of different
materials assessed using these methods can be carried out with the aid of computational modelling. This
approach can develop an understanding of the rules used to predict bacterial attachment to surfaces of
non-toxic synthetic materials. Here we outline our view on the state of this field and the challenges
and opportunities in this area for the coming years.
Statement of significance
This opinion article on high throughput screening methods reflects one aspect of how the field of bioma-
terials research has developed and progressed. The piece takes the reader through key developments in
biomaterials discovery, particularly focusing on need to reduce bacterial colonisation of surfaces. Such bac-
terial resistant surfaces are increasingly required in this age of antibiotic resistance. The influence and ori-
gin of high-throughput methods are discussed with insights into the future of biomaterials development
where computational methods may drive materials development into new fertile areas of discovery.
New biomaterials will exhibit responsiveness to adapt to the biological environment and promote better
integration and reduced rejection or infection.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
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Antimicrobial resistance has been predicted to rival cancer as
both a cause of death and an expense to healthcare systems by
2050 [1]. Bacteria inflict significant human suffering through acute
and chronic disease. Infection has serious impacts upon morbidity
and mortality [2,3]. Socio-economic factors associated with infec-
tious diseases have negative influences upon trade, commerce
and social development [4,5]. Infectious diseases are problematic
for both patients and society as a whole, for example the cost of
Clostridium difficile infections in the US alone is estimated at over
$796 million [6] and the total cost for healthcare-associated infec-
tions (HAI) is between $28 billion and $45 billion per year [7].
A recently published prevalence survey identified that in 2011
medical-device associated infections accounted for 25.6% of
healthcare associated infections [8]. Many types of devices, such
as venous catheters and prosthetic heart valves, become colonised
by bacteria which can subsequently form biofilms and cause infec-
tion and device failure [9]. In 2009 it was estimated that in the US
alone there are a quarter of a million central-line-associated blood-
stream infections annually leading to 31,000 deaths per year [7].
The treatment of device-associated infections often proves partic-
ularly challenging as micro-organisms within a biofilm are able
to protect themselves from the immune system and antibiotics
[10]. Bacteria are estimated to be 10–1000 times more tolerant
to host defences and antibiotics than in their planktonic state
[11,12]. For example the bactericidal concentration of a particular
systemic dose of vancomycin for Staphylococcus epidermidis
increases from 6.25 micrograms/mL to 400 micrograms/mL when
the bacterium moves from the planktonic state to form a biofilm
[13–16]. Following years of repeated and prolonged use and mis-
use of antibiotics, anti-microbial resistance is now a global threat
[17]. A preferred approach is therefore to avoid the use of antibi-
otics and biocidal agents and to prevent the development of device
associated infections by preventing surface colonisation and bio-
film formation.
The first stage of biofilm formation involves the initial attach-
ment of individual bacterial cells or small bacterial aggregates,
which is usually preceded by adsorption of biological macro-
molecules [11]. Systems designed to prevent bacterial attachment
aim to disrupt biofilms at the earliest possible stage. Polymer
materials are well suited to biofilm prevention. It has been shown
that they can be readily tailored by variation in their chemistry to
achieve non-fouling effects [22]. One problem is that the required
chemistry cannot readily be predicted from first principles.
The approaches employed to resist biofilm formation are either
the production of cytotoxic materials designed to kill bacteria upon
contact [18–20], which are unlikely to select for resistance [21], or
anti-adhesion strategies whereby the materials circumvent bacte-
rial attachment, biofilm formation and the hence associated
increase in resistance to antibiotics and host defences. Compared
to antibiotic containing materials, surfaces that resist bacterial
attachment do not induce the evolutionary pressure which would
lead to bacterial resistance. This characteristic means that this
class of material is of particular interest in an age of growing
antibiotic resistance. A number of anti-fouling polymer strategies
have recently been reviewed by Rosenhahn et al. [22]. The mecha-
nisms that have been employed to prevent attachment include
electrostatic repulsion, steric repulsion, topography and hydration.
Kosmotropes, which stabilise proteins in their native form, par-
ticularly poly(ethylene glycol) and zwitterionic polymers have
attracted the most research attention as anti-fouling films for their
ability to prevent cell attachment [23]. Their discovery through
early observations of their resistance to coating by proteins have
now led to wide spread use [24].Poly(ethylene glycol) acts by hydrogen bonding to up to three
water molecules per repeating ether group. Through this mecha-
nism, the complex is sterically stabilised. In order for protein to
adsorb the chains must be compressed and water released. The
removal of water from the chains has an enthalpic cost. The com-
pression of the chains has a corresponding entropic expense [25–
28]. However hydrophilicity and steric hinderance alone do not
explain its efficiency suggesting its unique solution properties con-
tribute to its non-fouling ability [29]. Zwitterionic polymers are
electrically neutral yet tightly co-ordinate water through ionic
interactions. This results in a highly hydrophilic surface [30] where,
similarly, the removal of water is entropically unfavourable [22].
However, protein adhesion is a process which one can reason-
ably assume may be described by physicochemical processes. It
is well known that mammalian cellular adhesion is regulated by
protein adsorption through integrin–peptide interactions [31].
There have been attempts to use physicochemical parameters to
explain bacterial attachment [21,32,33]. Recently superwettable
materials have gained interest to aid understanding of bacterial
interactions with certain materials. Bacterial surface components
such as peptidoglycan have shown to influence adherence with
surfaces of varying hydrophilicity [34]. However predicting attach-
ment across our wide chemical libraries using water contact angle
has not been successful, apart from in very limited subsets of sim-
ilar materials, leading us to conclude that the use of the wettability
as a surface descriptor (hydrophobic or hydrophilic) is not helpful
in understanding bacterial–surface interactions [35]. This points to
the importance of sophisticated bacterial sensing mechanisms and
downstream cellular responses in determining their responses to a
specific material. Bacterial cells do not behave as inanimate objects
but possess complex regulatory network systems for sensing and
mechanics, for example type IV pili [25,29,36] and other fimbrial
types [37] that help determine their reactions to different surfaces.
This flexibility presents a difficult problem to identify attachment
resistance surfaces.
Despite significant on-going research into anti-adhesive sur-
faces there has been a lack of translation from successful
laboratory-based systems to clinically useful medical devices,
many of which still employ high-fouling surfaces. Some instances
where translation has been successful include the PolySB coating
based upon work by Loose et al. at Massachusetts Institute of Tech-
nology [38] and AvertTM, a poly(ethylene glycol) and biguanide
coating produced by Biointeractions Limited [39]. Using an drug
eluting system, J. Kohn developed TYRXTM which employs a poly-
mer discovered in a high throughput screening campaign. The pro-
duct is constructed of a polymer, containing rifampicin and
minocycline which may be absorbable or non-absorbable [40]. A
retrospective, observational analysis demonstrated the coating to
reduce the risk of infections and patient mortality [41].
Busscher et al. discussed the issues facing translation of out-
comes from scientific studies into successful biomedical devices.
The delicate interplay between bacteria and host cells, such as
epithelial cells, that leads to colonisation of an implanted surface
has, thus far, been difficult to replicate in laboratory studies.
Improving these ex vivo models should help improve translation
to the clinic [42]. These experimental issues are compounded by
the number of patients and the duration required for clinical trials
to demonstrate efficacy and safety unequivocally [43]. Beyond
innovation barriers, new approaches are required between aca-
demic discovery groups and those in industrial and regulatory areas
to increase translation to improve health outcomes [9]. For exam-
ple, in academia there is a need to publish and this can often be pre-
ceded by inadequate patenting or none at all. They believe that this
lack of intellectual property demotivates industrial players from
developing new ideas which could drive further translation.
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Existing biomedical materials have arisen from a combination
of accessibility and utility. For example silicone rubber, originally
developed as an electrical insulator, finds common application as
a medical device material due to its useful mechanical properties
and inert nature. Polymethacrylates originally used in the plastic
canopies on warplanes were subsequently exploited for use in
intraocular lenses since it was noted that polymer fragments
trapped in pilots’ eyes were well tolerated [44]. Whilst the
mechanical and other bulk properties may be optimal for these
materials for a given application, the tendency to promote bacterial
attachment and biofilm formation is not. Consequently, modifica-
tion of these basic materials offers one route to new biomaterials
which has been explored, e.g. copolymerisation and surface func-
tionalisation. However, an alternative is to start afresh and ask
the question, what would the optimal material be for a particular
application? The aim of this article is to guide the reader through
steps taken thus far to control bacterial biomaterial interactions
and how this area could develop in a different but exciting direc-
tion by answering this question.
Over the last decade, dramatic advances have been made
through both hypotheses relating material properties to cellular
responses, and discovery of new materials made using high-
throughput screening [45–49]. Useful illustrations of the step
change jumps in knowledge are the material property-cell
differentiation relationships characterised for mesenchymal cells.
These include Engler and Discher’s data that substrate stiffness
could direct stem cell fate [50], Dalby and Oreffo’s observation that
nanotopography could control cell differentiation [51] and
Anseth’s correlation of chemistry in 3D cell encapsulating gels with
differentiation lineage [52]. However the relative contributions of
these effects on cell fate are poorly defined and similar relation-
ships have not been established for microbial cells.
Despite these advances, rational design of new biomaterials is
still hindered by the paucity of information on the physicochemical
parameters governing the response of different cell types of inter-
est to a broad range of materials.2.1. High-throughput approaches
The rational design roadblock for biomaterials has promoted an
interest in the application of data driven, high-throughput screen-
ing approaches that can be applied to any cell type and adapted to
model a particular application area/service environment [53].
Mounting screening campaigns with large material libraries could
be referred to as engineering ‘‘happy accidents”, or serendipity. This
was first illustrated in 2004 for polymer micro arrays by Anderson
et al. [55] for stem cells and also exemplified by the Bradley group
[56]. In addition to the identification of hit materials for further
development towards materials for cell control, the large amount
of information generated on the biointerface can be used to obtain
new insights. To achieve structure–property relationships requires
analysis of the surface chemistry rather than assumption of its
identity from the input monomers, which is where the develop-
ment of high-throughput surface characterisation has been critical
[57,58]. This has facilitated correlations of the surface chemistry
and monomer identity with bacterial attachment to move towards
rational design [59,60], combining an understanding of both the
organism and materials to propose new biomaterials ab initio [61].
The success of the data driven scientific method illustrated
using the high-throughput screening approach demonstrates the
validity of its application for materials discovery. Recently, Autef-
age et al. used a non-reductionist approach to understand the
influence of strontium ion incorporation into 45S5 bioactive glass.Their unbiased investigation found a number of changes, including
increases in cellular and membrane cholesterol content and in
phosphorylated myosin II light chain which may not have be iden-
tified from biological predictions alone [65]. This contrasts with
reductionist approaches favourably, indicating the need to identify
new materials but then understand their mode of action through
hypothesis driven investigation [54].
Brocchini et al. in 1998 applied the combinatorial materials
screening approach to polymeric biomaterials discovery. The
authors synthesised separately but in parallel, 112 biodegradable
polyacrylates from 8 aliphatic diacids and 14 diphenols before sub-
sequent surface coating and testing [69]. Significantly, the authors
discovered that while increasing the surface wettability improved
fibroblast growth, backbone substitution with an oxygen also
improved growth without affecting surface hydrophilicity. This
showed that single characteristics such as water contact angle
(WCA) cannot be used to guide material development for complex
living systems. The procedure allowed many materials and their
characteristics to be analysed, however, the separate syntheses
and subsequent coating made the process unacceptably slow for
ultra high-throughput novel materials discovery where rapid evo-
lution from one generation to the next in response to cell response
data is desirable.
In order to optimise the rate at which new biomaterials could
be discovered and their biological properties assessed, the microar-
ray format has now become routine. In this way, hundreds of
unique polymers are generated on-slide and assayed on a single
substrate in a single experiment. The group of Langer et al. first
published the use of microarrays to screen hundreds of materials
for their effects upon the growth and differentiation of human
stem cells [55]. This initial report described 576 unique polymers
in triplicate, generated in situ by printing monomers pairwise into
an array and curing using UV on 25  75 mm pHEMA coated glass
slides (Fig. 1). Commercial monomers were employed to enable
ready access to a large chemical space.
This enabled rapid, simultaneous assays to be carried out in par-
allel. The new platform set the precedent for high-throughput
material discovery for the purposes of controlling cell attachment
and growth including bacteria [48,49]. The different methods
which can be used to prepare microarrays have been reviewed
recently in the literature [70].
Subsequently, there have been a number of notable successes
for the high-throughput screening approach for discovery of novel
biomaterials including the identification of a new class of polymers
resistant to bacterial attachment that has potential as medical
device coatings [71]. More recently, also a series of materials that
allow long term renewal of pluripotent stem cells [46]. These finds
have been achieved using unbiased screening or ‘‘fishing expedi-
tions” a commonly used pejorative description of this approach.
When considering materials from which to manufacture medi-
cal devices with reduced rates of infections, the question is, are
there materials better at resisting attachment of bacteria than
poly(ethylene glycol) and zwitterionic polymers? The extension
of the high-throughput platform was a logical transition to emu-
late the successes seen with eukaryotes. Pernagallo et al. produced
an early report of an array to identify specific bacteria binding/non-
binding polymers. The authors used clinically relevant strains and
identified polyacrylate materials which had properties of high
binding, low binding and selective binding [72]. The Bradley group
later screened a 381 polymer library with up to eleven different
bacterial strains/species including those obtained from endotra-
cheal tubes or from patients with infectious endocarditis
(BacMix-1 and BacMix-2). Further to their high-throughput screen
a number of ‘‘hit” polyurethane and polyacrylates/acrylamides
were identified. The hit coating, which was a co-polymer of
methylmethacrylate and dimethylacrylamide in a molar ratio of
Fig. 1. (a–c) Six million human embryonic stem (hES) cell embryoid body day-6 cells were inoculated on the polymer array in the presence of retinoic acid for 6 d and then
stained for cytokeratin 7 (green) and vimentin (red). Polymer spots can be identified by blue fluorescence. (d) Nuclei were also stained (green) (not shown in other images to
simplify presentation). (e) Typical cytokeratin 7 positive spot on polymer composed of 100% monomer 9. (f) Cell attachment and growth as a function of polymer composition,
measured as the average percent cell coverage of a polymer spot on day 6. Although the vast majority of polymers remained attached to the matrix during analysis, certain
hydrophilic polymers (such as those composed of 30% monomer *) did fall off after extensive submersion [55].
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Fig. 2. (A) Confocal fluorescence images (40 magnification, kex 405 nm, kem 414–502 nm) of catheter surfaces showing bacteria binding/non-binding. The images were
obtained after 72 h incubation with bacteria, followed by washing, fixing and staining with DAPI (1 lg mL1). (a and b) Uncoated Cath-1, (c and d) uncoated Cath-2,
(e and f) Cath-1-PA13, (g and h) Cath-2-PA13, (i and j) Cath-1-PA515, (k and l) Cath-2-PA515. (B) The percentage of surface area covered by bacteria after 72 h incubation with
BacMix-1 and BacMix-2, and (C) percentage of reduction in bacterial binding, obtained by comparing the area of bacterial coverage to the area of the image. PA13 Co-polymer
of methylmethacrylate and dimethylacrylamide (9:1 monomer ratio) PA515 Co-polymer of methoxyethylmethacrylate, diethylaminoethylacrylate and methylmethacrylate
(6:1:3 monomer ratio) [73].
88 E.P. Magennis et al. / Acta Biomaterialia 34 (2016) 84–929:1 (PA13), generated P96% reduction for the bacteria mixtures
tested using a microaerobic environment and supplementing
growth with BHI after 24 and 48 h (Fig. 2) [73].
The surface characteristics and properties of materials obtained
from combinatorial methods cannot be entirely rationalised based
upon the composition assumed from the raw materials used for
synthesis, and as such surface analysis is a key component for
understanding the materials’ behaviour [60]. To understand,
explain and develop a biological observation from novel materials,
the surface characteristics need to be described [70]. Traditional
polymer characterisation methods do not generally provide infor-
mation on the upper-most surface which controls cellular response
to materials. This is problematic as importantly it is the surfaces of
the materials which dictate the observed phenomena. To circum-
vent this analytics barrier, surface analysis techniques such as timeof flight secondary ion mass spectroscopy (ToF-SIMS) [57,58],
atomic force microscopy (AFM) [74], surface wettability measured
through water contact angles (WCA) [75], surface plasmon reso-
nance (SPR) [76] and X-ray photoelectron spectroscopy (XPS)
[58] allow for rapid characterisation of polymer microarrays.
Together with the microarray format, these techniques are known
as high-throughput surface characterisation (HTSC) [77].
The polymer array and combinatorial approach can be used to
perform a biased screen, when the identity of the members of
the library on the array are chosen in order to test preconceived
notions of the function of certain monomer or monomer combina-
tions when combined to make polymers. Alternatively an unbiased
screen can be performed where the aim is to cover as wide a
chemical space as possible in the hope that unexpected relation-
ships may be discovered. This most exciting screening method
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als and materials classes. After the response to a surface has been
described, the nature of any interconnectiveness between the
surface analysis data and biological response can be explored.
ToF-SIMS surface analysis data is complex and multivariate. In
order to overcome the challenge of information overload a mathe-
matical technique called Partial Least Squares (PLS) has beenFig. 3. (a) Bacterial attachment assay procedure; (b–f) Intensity maps of F measured for e
aeruginosa (b), Staphylococcus aureus (c), Uropathogenic Escherichia coli (UPEC) (d), UPEC
(f). (g) Intensity map of the bacterial performance obtained for each material in the arra
culture conditions. The major monomers are listed on the y-axis whereas the compositio
outlined area indicates the mean value, and the mean ± 1 s.d. unit is presented in the na
square-root scale is applied to the intensity indicators. (h) The average normalised fluores
highest. The major and minor monomers were considered separately. The colour next to
intensity scale as in g [49].applied. This is done to correlate multivariate datasets such as
surface analysis to univariate data, for example the observed bio-
logical response [78]. This was successfully used to correlate the
attachment of human embryoid body cells with the surface chem-
istry of the materials as measured by ToF-SIMS [77].
The ToF-SIMS technique is versatile and has been used to iden-
tify key spectral ions responsible for reduced or increased bacterialach bacterial strain on the first-generation array after 72-h incubation; Pseudomonas
grown in artificial urine (e) and UPEC grown on an artificial urine-conditioned slide
y, given as a percentage of the maximum bacterial numbers for all strains under all
n of the minor monomers is shown on the x-axis. The large shaded area within each
rrow columns to the right (plus) and left (minus) of the mean, n = 3. Key to right. A
cent intensity for all materials containing a specific monomer, ranked from lowest to
each monomer is indicative of that monomer’s mean i and is coloured by the same
90 E.P. Magennis et al. / Acta Biomaterialia 34 (2016) 84–92attachment to a library of polymers [49]. Hook et al. generated an
expansive combinatorial polymer microarray from 22 commer-
cially available acrylate monomers. These were combined in
varying ratios to create 496 unique polymers obtained through
photo-initiated free-radical polymerisation. The array was incu-
bated with fluorescent bacteria for three days and the resulting
attachment or resistance to bacteria was quantified from the fluo-
rescent signal (i) on each polymer surface (Fig. 3).
The observed fluorescent signal could be predicted using linear
PLS correlation for the bacteria Pseudomonas aeruginosa and
Staphylococcus aureus. Cyclic hydrocarbons, esters, tertiary butyl
moieties and non-aromatic hydrocarbons were identified from
the ToF-SIMS signals as key to reduce bacterial attachment.
This contrasted with ethylene glycol and hydroxyl groups that
were found to correlate with higher bacterial attachment. These
insights were used for the selection of ‘hit’ monomers to be used
in a subsequent generation array that screened copolymer series
for formulation optimisation. Furthermore, the chemical fragments
associated with low bacterial attachment provided insight into
the physio-chemical mechanism by which the polymers resisted
bacteria. Specifically, the association of both the hydrophilic ester
groups and hydrophobic cyclic hydrocarbon groups with low
bacterial attachment suggested that the weakly amphiphilic nat-
ure of the polymers was key to their function. The scaled up mate-
rial showed a thirty-fold reduction in biofilm formation compared
to commercial antibacterial silver hydrogel. In the group’s later
work, the microarray was expanded to generate 1273 individual
polymers and clinically isolated pathogenic bacterial strains were
included in the screen. From this larger screen, a greater number
of materials had their antibacterial properties investigated. Lead
hit materials showed up to 99% fewer bacteria attached compared
to an antibacterial silver hydrogel [48].
2.2. Materiomic approaches
The number of potential polymers that could be synthesised are
innumerable, thus, it is not experimentally feasible to screen all
possible materials even utilising high-throughput screening meth-Fig. 4. Process of computational modelling for the generation of novel biomaterials. Mate
molecular descriptors. The model is then used to predict new untested materials which
testing.ods. To truly assess the interaction of bacteria with the polymeric
materials space another approach is required. The use of materi-
omics, involving computational and experimental approaches with
large datasets for biomaterial discovery has recently been
reviewed in a number of books and reviews [61,79,80].
Computational methods including quantitative structure–prop-
erty relationships (QSPR) [81] are set to guide experimentation to
potentially fertile new areas of chemical space using surface
structure-performance relationships from both experimental
molecular descriptor – bacterial response relationships and surface
analytical – bacterial response data sets. Hypotheses can be formed
and tested using cellular attachment information and the ToF-SIMS
data to produce descriptors that can guide improved material
development and resistance to bacterial attachment and colonisa-
tion. For a limited set of polymers, Sanni et al. developed a molec-
ular descriptor parameter a (Eq. 1) that was found to correlate with
bacterial cell resistance [35].
a ¼ 0:44nRoTB clogP ð1Þ
This equation links chemical parameters of a biomaterial by the
number of rotational bonds (nRotB) and hydrophobicity (clogP) to
bacterial attachment on that surface. The challenge in this area, as
it was for drug discovery, is to project outside the training set, to
identify candidates outside the modelled materials space (Fig. 4).
The complex data processing requires machine learning sys-
tems capable of complex pattern recognition [82] beyond that
achieved by PLS modelling [60]. Epa et al. in 2014 utilised a
machine learning modelling approach to predict the attachment
of P. aeruginosa, S. aureus and Escherichia coli to polymer surfaces
from a library of computationally derived molecular descriptors
[59]. Following predictions of attachment, several monomers that
had not been used to generate the models were tested for their
propensity for colonisation by P. aeruginosa. The model success-
fully predicted those monomers that would produce high and
low adherent surfaces. A number of molecular descriptors were
invoked to explain the bacterial attachment to the materials,
including those incorporating the number and type of chemical
functional groups in the polymers, descriptors relating to therials are screened from a library of materials and cell responses are modelled against
are to be synthesised and tested. Optimised materials are then scaled up for in vivo
E.P. Magennis et al. / Acta Biomaterialia 34 (2016) 84–92 91ability of the polymers to form hydrogen bonds (relevant to biofilm
formation), the dipole moments, surface wettability, molecular
shape, and complexity. The successful utility of these descriptors
to predict the biological performance of the materials suggests
these properties play a key role in determining how bacteria attach
or do not attach. As such, predictive models are useful not only as a
materials development tool but also at providing novel insights
into the underlying biological–material interactions. The ultimate
goal is for modelling techniques to allow us to ‘‘dial up” biomateri-
als and drugs based upon the desired characteristics while min-
imising experimental time. Although this is far from where we
are currently with biomaterials, one can look to the in silico design
of aerospace components for inspiration.3. Future outlook
Polymers offer many advantages as a material platform for
manipulating bacteria–biomaterial interactions. Polyvalency and
intricate property manipulation can allow for the development of
precision surfaces and materials. The ability to produce polymers
in a variety of formats, for example as three dimensional networks,
soluble agents and surface coatings, allows for their application to
a variety of analytic formats and uses.
Understanding the interactions of bacteria with biomaterials
may be a route to improve functionality. Such intelligence-led
approaches have been demonstrated and are guided by knowledge
of organisms and their attachment processes [36,37,65]. However,
the colonisation process, for example, is complex and not all steps
are known and understood.
However, the future goal is not simply to prevent bacterial
attachment but also to control the specific biological responses
to a surface. Research is already underway into bioinspired devices
where ligands and proteins direct cell behaviours such as colonisa-
tion and proliferation, so called ‘‘third generation” biomaterials
[33]. Beyond this third generation, biomaterials should encourage
integration of man-made devices yet be able respond appropriately
to biological or chemical cues should infection or rejection occur.
For example pH responsive materials have been demonstrated to
self-clean in response to local pH reductions due to bacteria coloni-
sation [31]. For greater integration, enzymatic or other cell
responses could be used to direct the behaviour of the material.
Magennis et al. recently showed a ‘bio-inspired’ approach in
which bacterial enzymes mediate polymer synthesis at a cell sur-
face and produces materials more favourable to cell binding than
those synthesised in the absence of bacteria [83]. In this work it
was demonstrated that polymers with co-monomer incorporation
dependent on the templating bacterial species could be formed
through polymerisation in the presence of cells. Utilising changes
in redox potentials as a result of cell enzyme cascades combined
with copper-mediated radical polymerisation and ‘‘click” chem-
istry, polymerswith specific affinity to the templatewere generated
in situ. Furthermore, fluorescent tagging of the polymers could take
place at the bacterial surfaces directed by the same enzymes. This
work showed how in complex biological systems, living processes
and cell metabolism can be utilised to direct material properties.
Combining these kinds of cellular biological pathways with third
generation biomaterials and integrating their development into
high-throughput screening approaches may lead to biomedical
devices with much-improved functionalities for the future.
In summary, high-throughput strategies are leading to novel
materials discoverywhen large numbers can be screened and ‘‘hits”
identified retrospectively rather than planning those to yield posi-
tive results. Looking forward, despite the advantages of high-
throughput methods, due to the vast variety of polymers which
could potentially be synthesised, it is anticipated that we will seethe increasing prominence of computation guided screening cam-
paigns where initial descriptive results are then modelled and the-
oretical hits generated fromvirtual libraries. This approachwill help
to facilitate the next generation of highly functional polymer mate-
rials for safe, fully integrated biomedical devices and technologies.Disclosures
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